– Interventional Radiologist, Tumor Embolization China
Future trends such as immunotherapy used in combination with embolization technologies is gaining prominence. Expanded indications of embolization to treat cancer types such as prostate cancer and cholangiocarcinoma is expected to increase as clinical evidence suggests good patient outcomes.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as recent NMPA approval of Sirtex Medical’s SIR-Sphere Y-90 resin microsphere for treatment of patients with colorectal cancer liver metastasis; China Grand Pharmaceutical’s acquisition of rights from Shenming Medical Technology Company of an innovative thermosensitive embolic agent for the treatment of liver cancer are covered in the report.